Sandostatin LAR Depot injection and Ustekinumab Intravenous Infusion
Determining the interaction of Sandostatin LAR Depot injection and Ustekinumab Intravenous Infusion and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sandostatin LAR Depot injection-Ustekinumab Subcutaneous
- Sandostatin LAR Depot injection-Ustekinumab Subcutaneous Injection
- Sandostatin LAR Depot injection-Ustell
- Sandostatin LAR Depot injection-UTA
- Sandostatin LAR Depot injection-UTA Capsules
- Sandostatin LAR Depot injection-UTAC tablets
- Ustekinumab Intravenous Infusion-Sani-Supp
- Ustekinumab Intravenous Infusion-Sani-Supp rectal
- Ustekinumab Intravenous Infusion-Sansert
- Ustekinumab Intravenous Infusion-Santyl
- Ustekinumab Intravenous Infusion-Saphris
- Ustekinumab Intravenous Infusion-Sapropterin